Centiva Capital’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$196K Sell
31,526
-5,018
-14% -$29.5K ﹤0.01% 1416
2026
Q1
$162K Buy
36,544
+9,358
+34% +$55.3K ﹤0.01% 1322
2025
Q4
$145K Buy
27,186
+942
+4% +$7.49K ﹤0.01% 1033
2025
Q3
$252K Buy
+26,244
New +$242K ﹤0.01% 798
2025
Q1
– Sell
-33,714
Closed -$153K – 1545
2024
Q4
$153K Buy
+33,714
New +$179K ﹤0.01% 1428
2024
Q3
– Sell
-33,171
Closed -$102K – 2120
2024
Q2
$102K Buy
+33,171
New +$128K ﹤0.01% 1850

Other funds holding ASPI

Centiva Capital's ASPI Position: Q2 2026 in Review

Centiva Capital reduced its ASP Isotopes (ASPI) stake by 14% in Q2 2026, selling an estimated $29.5K and leaving 31,526 shares worth $196K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

Centiva Capital first reported a position in ASPI in Q2 2024 and has held it in 6 quarters since. The position peaked at $252K in Q3 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Centiva Capital held 31,526 shares of ASP Isotopes worth $196K as of Q2 2026.
  • Centiva Capital sold 5,018 ASP Isotopes shares in Q2 2026, an estimated $29.5K.
  • ASP Isotopes made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1416 holding.
  • Centiva Capital first reported a position in ASP Isotopes in Q2 2024 and has held it in 6 quarters since.
  • Centiva Capital's ASP Isotopes position peaked at $252K in Q3 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.